Gilead Sciences completes acquisition of Pharmasset, Inc.
17 January 2012 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced the completion to acquire Pharmasset, Inc...
List view / Grid view
17 January 2012 | By Gilead Sciences Inc
Gilead Sciences, Inc. announced the completion to acquire Pharmasset, Inc...
17 January 2012 | By FOSS NIRSystems, Inc.
Service Pack 7 has been released for Vision 3.50, a software package designed for use with the FOSS NIRSystems Near-Infrared laboratory and process analyzers...
17 January 2012 | By Pfizer
Dimebon did not meet primary efficacy endpoints...
16 January 2012 | By Weber Shandwick
Enrolment of the first patient into the PREvention oF thromboembolic events...
16 January 2012 | By H. Lundbeck A/S
H. Lundbeck A/S has crowned six years of focused efforts on productivity improvements with a silver medallion...
13 January 2012 | By Novartis
US General Medicines restructuring results in reduction of 1,960 positions...
13 January 2012 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company is commencing a cash tender offer to purchase all outstanding shares of common stock of Inhibitex...
12 January 2012 | By Gilead Sciences
Following the merger, Pharmasset will become a wholly-owned subsidiary of Gilead...
12 January 2012 | By B&W Tek Inc
B&W Tek, Inc., is proud to introduce the BAC200...
12 January 2012 | By B&W Tek, Inc
In the last 15 years B&W Tek has experienced substantial growth in size, value, skills and core competencies...
IFF, a leading global creator of flavors and fragrances, uses the Syrris Atlas Calorimeter for flavor and fragrance development at its production plant in Benicarlo, Spain.
11 January 2012 | By kdm communications limited
Tecan’s Infinite® M1000 multimode microplate reader has enabled scientists to develop a high throughput system...
11 January 2012 | By GlaxoSmithKline
GlaxoSmithKline respectfully disagrees with the recent court ruling in favour of ANMAT...
11 January 2012 | By AstraZeneca
AstraZeneca has entered into a three-year collaboration agreement with IMS Health...
10 January 2012 | By Sanofi
Sanofi is co-investing in Warp Drive Bio, an innovative start-up biotechnology company...